Amelioration of experimental colitis by a novel nanoselenium–silymarin mixture

References

• Abdolghaffari AH, Baghaei A, Moayer F, Esmaily H, Baeeri M, Monsef-Esfahani HR, Hajiaghaee R, Abdollahi M. 2010. On the benefit of Teucrium in murine colitis through improvement of toxic inflammatory mediators. Hum Exp Toxicol 29:287–295.
   PubMed Web of Science ®Google Scholar
• Abdollahi M, Rahmat-Jirdeh N, Soltaninejad K. 2001. Protection by selenium of lead-acetate-induced alterations on rat submandibular gland function. Hum Exp Toxicol 20:28–33.
   PubMed Web of Science ®Google Scholar
• Amini-Shirazi N, Hoseini A, Ranjbar A, Mohammadirad A, Khoshakhlagh P, Yasa N, Abdollahi M. 2009. Inhibition of tumor necrosis factor and nitrosative/oxidative stresses by Ziziphora clinopoides (Kahlioti); a molecular mechanism of protection against dextran sodium sulfate-induced colitis in mice. Toxicol Mech Methods 19:183–189.
   PubMed Web of Science ®Google Scholar
• Arteel GE, Briviba K, Sies H. 1999. Protection against peroxynitrite. FEBS Lett 445:226–230.
   PubMed Web of Science ®Google Scholar
• Astaneie F, Afshari M, Mojtahedi A, Mostafalou S, Zamani MJ, Larijani B, Abdollahi M. 2005. Total antioxidant capacity and levels of epidermal growth factor and nitric oxide in blood and saliva of insulin-dependent diabetic patients. Arch Med Res 36:376–381.
   PubMed Web of Science ®Google Scholar
• Blumberg RS, Saubermann LJ, Strober W. 1999. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 11:648–656.
   PubMed Web of Science ®Google Scholar
• Bouma G, Strober W. 2003. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3:521–533.
   PubMed Web of Science ®Google Scholar
• Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem 72:248–254.
   PubMed Web of Science ®Google Scholar
• Duntas LH. 2009. Selenium and inflammation: underlying anti-inflammatory mechanisms. Horm Metab Res 41:443–447.
   PubMed Web of Science ®Google Scholar
• Esmaily H, Hosseini-Tabatabaei A, Rahimian R, Khorasani R, Baeeri M, Barazesh-Morgani A, Yasa N, Khademi Y, Abdollahi M. 2009. On the benefits of silymarin in murine colitis by improving balance of destructive cytokines and reduction of toxic stress in the bowel cells. Cent Eur J Biol 4:204–213.
   Google Scholar
• Fesharaki PJ, Nazari P, Shakibaie M, Rezaie S, Banoee M, Abdollahi M, Shahverdi AR. 2010. Biosynthesis of selenium nanoparticles using Klebsiella pneumonia and their recovery by a simple sterilization process. Braz J Microbiol. 41:461–466.
   PubMed Web of Science ®Google Scholar
• Gazák R, Walterová D, Kren V. 2007. Silybin and silymarin—new and emerging applications in medicine. Curr Med Chem 14:315–338.
   PubMed Web of Science ®Google Scholar
• Ghazanfari G, Minaie B, Yasa N, Nakhai LA, Mohammadirad A, Nikfar S, Dehghan G, Boushehri VS, Jamshidi H, Khorasani R, Salehnia A, Abdollahi M. 2006. Biochemical and histopathological evidences for beneficial effects of satureja khuzestanica jamzad essential oil on the mouse model of inflammatory bowel diseases. Toxicol Mech Methods 16:365–372.
   PubMed Web of Science ®Google Scholar
• Hanauer SB. 2006. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 12 (Suppl 1):S3–S9.
   PubMed Web of Science ®Google Scholar
• Hosseini-Tabatabaei A, Abdollahi M. 2008. Potassium channel openers and improvement of toxic stress: do they have role in the management of inflammatory bowel disease? Inflamm Allergy Drug Targets 7:129–135.
   PubMedGoogle Scholar
• Inoue J, Gohda J, Akiyama T, Semba K. 2007. NF-kappaB activation in development and progression of cancer. Cancer Sci 98:268–274.
   PubMed Web of Science ®Google Scholar
• Jurjus AR, Khoury NN, Reimund JM. 2004. Animal models of inflammatory bowel disease. J Pharmacol Toxicol Methods 50:81–92.
   PubMedGoogle Scholar
• Katiyar SK, Roy AM, Baliga MS. 2005. Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/Bax, cytochrome c release, and caspase activation. Mol Cancer Ther 4:207–216.
   PubMed Web of Science ®Google Scholar
• Khoshakhlagh P, Bahrololoumi-Shapourabadi M, Mohammadirad A, Ashtaral-Nakhai L, Minaie B, Abdollahi M. 2007. Beneficial effect of phosphodiesterase-5 inhibitor in experimental inflammatory bowel disease; molecular evidence for involvement of oxidative stress. Toxicol Mech Methods 17:281–288.
   PubMed Web of Science ®Google Scholar
• Kreydiyyeh SI, Al-Sadi R. 2002. The mechanism by which interleukin-1 beta reduces net fluid absorption from the rat colon. Eur Cytokine Netw 13:358–363.
   PubMed Web of Science ®Google Scholar
• Malihi F, Hosseini-Tabatabaei A, Esmaily H, Khorasani R, Baeeri M, Abdollahi M. 2009. Improvement of inflammatory and toxic stress biomarkers by silymarin in a murine model of type one diabetes mellitus. Cent Eur J Biol 4:369–380.
   Google Scholar
• Manna SK, Mukhopadhyay A, Van NT, Aggarwal BB. 1999. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis. J Immunol 163:6800–6809.
   PubMed Web of Science ®Google Scholar
• Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. 1989. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96:795–803.
   PubMed Web of Science ®Google Scholar
• Nakhai LA, Mohammadirad A, Yasa N, Minaie B, Nikfar S, Ghazanfari G, Zamani MJ, Dehghan G, Jamshidi H, Boushehri VS, Khorasani R, Abdollahi M. 2007. Benefits of Zataria multiflora Boiss in experimental model of mouse inflammatory bowel disease. Evid Based Complement Alternat Med 4:43–50.
   PubMed Web of Science ®Google Scholar
• Neurath MF, Becker C, Barbulescu K. 1998. Role of NF-kappaB in immune and inflammatory responses in the gut. Gut 43:856–860.
   PubMed Web of Science ®Google Scholar
• Pavlick KP, Laroux FS, Fuseler J, Wolf RE, Gray L, Hoffman J, Grisham MB. 2002. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. Free Radic Biol Med 33:311–322.
   PubMed Web of Science ®Google Scholar
• Peng D, Zhang J, Liu Q, Taylor EW. 2007. Size effect of elemental selenium nanoparticles (nano-Se) at supranutritional levels on selenium accumulation and glutathione S-transferase activity. J Inorg Biochem 101:1457–1463.
   PubMed Web of Science ®Google Scholar
• Radfar M, Larijani B, Hadjibabaie M, Rajabipour B, Mojtahedi A, Abdollahi M. 2005. Effects of pentoxifylline on oxidative stress and levels of EGF and NO in blood of diabetic type-2 patients; a randomized, double-blind placebo-controlled clinical trial. Biomed Pharmacother 59:302–306.
   PubMed Web of Science ®Google Scholar
• Rahimi R, Nikfar S, Abdollahi M. 2007. Do anti-tumor necrosis factors induce response and remission in patients with acute refractory Crohn’s disease? A systematic meta-analysis of controlled clinical trials. Biomed Pharmacother 61:75–80.
   PubMed Web of Science ®Google Scholar
• Rayman MP. 2000. The importance of selenium to human health. Lancet 356:233–241.
   PubMed Web of Science ®Google Scholar
• Rezaie A, Ghorbani F, Eshghtork A, Zamani MJ, Dehghan G, Taghavi B, Nikfar S, Mohammadirad A, Daryani NE, Abdollahi M. 2006. Alterations in salivary antioxidants, nitric oxide, and transforming growth factor-beta 1 in relation to disease activity in Crohn’s disease patients. Ann N Y Acad Sci 1091:110–122.
   PubMed Web of Science ®Google Scholar
• Rezaie A, Parker RD, Abdollahi M. 2007. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig Dis Sci 52:2015–2021.
   PubMed Web of Science ®Google Scholar
• Sanchez-Munoz F, Dominguez-Lopez A, Yamamoto-Furusho JK. 2008. Role of cytokines in inflammatory bowel disease. World J Gastroenterol 14:4280–4288.
   PubMed Web of Science ®Google Scholar
• Sandborn WJ, Hanauer SB. 1999. Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. Inflamm Bowel Dis 5:119–133.
   PubMed Web of Science ®Google Scholar
• Soleimani H, Ranjbar A, Baeeri M, Mohammadirad A, Khorasani R, Yasa N, Abdollahi M. 2008. Rat plasma oxidation status after Nigella sativa L. botanical treatment in CCL(4)-treated rats. Toxicol Mech Methods 18:725–731.
   PubMed Web of Science ®Google Scholar
• Tirosh O, Levy E, Reifen R. 2007. High selenium diet protects against TNBS-induced acute inflammation, mitochondrial dysfunction, and secondary necrosis in rat colon. Nutrition 23:878–886.
   PubMed Web of Science ®Google Scholar
• Vunta H, Davis F, Palempalli UD, Bhat D, Arner RJ, Thompson JT, Peterson DG, Reddy CC, Prabhu KS. 2007. The anti-inflammatory effects of selenium are mediated through 15-deoxy-delta12,14-prostaglandin J2 in macrophages. J Biol Chem 282:17964–17973.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang J, Yu H. 2007. Elemental selenium at nano size possesses lower toxicity without compromising the fundamental effect on selenoenzymes: comparison with selenomethionine in mice. Free Radic Biol Med 42:1524–1533.
   PubMed Web of Science ®Google Scholar
• Zamamiri-Davis F, Lu Y, Thompson JT, Prabhu KS, Reddy PV, Sordillo LM, Reddy CC. 2002. Nuclear factor-kappaB mediates over-expression of cyclooxygenase-2 during activation of RAW 264.7 macrophages in selenium deficiency. Free Radic Biol Med 32:890–897.
   PubMed Web of Science ®Google Scholar